We use our own and third party cookies in order to improve our performance, and to obtain anonymous statistics about the use of the website. By continuing to browse, you authorize their use. In order to change the preferences and to obtain further information, please refer to our cookies policy.


Our Areas of Interest

The Immunology and Vaccines Business Unit develops vaccines using a recombinant protein approach. We are interested in exploring collaborations related to the fields of:

  • Leishmaniasis
  • Parasitic Diseases
  • Immunological Diseases
  • Infectious Diseases

In addition, we have several novel adjuvants that could potentially improve the effectiveness of antigens targeted at any disease.